Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: January 2007
-
By Jason Derry — Amgen Inc. has announced that it will collaborate with Cytokinetics to generate small-molecule therapeutics for treating heart failure. In particular, the agreement relates to discovery, development, and commercialization of compounds that activate cardiac myosin. Cytokinetics has identified a particular cardiac myosin activator, CK-1827452, that is currently its lead drug…
-
By Jason Derry — Sigma-Aldrich has announced that it has agreed to give Pfizer a non-exclusive, worldwide license to use DNA-directed RNAi (ddRNAi) for research purposes. Sigma-Aldrich has an exclusive license to the ddRNAi technology (excluding the right to develop ddRNAi for therapeutic use in humans) from Benitec Ltd. and Australia's CSIRO (Commonwealth…
-
By Sherri Oslick — We have reported here and here on Savient Pharmaceuticals, Inc. v. Sandoz, Inc. and Upsher-Smith Laboratories, Inc., 2:06-cv-05782, filed December 4, 2006 in the District Court of New Jersey. The district court judge had granted, then vacated, the temporary restraining order sought by Savient to prevent Sandoz from taking any…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma patent cases. A few interesting cases will be selected for periodic monitoring, providing our readers with an opportunity to follow the progress of these cases. Celgene Corp. and Novartis Pharmaceutical Corp. et. al. v.…
-
By Donald Zuhn — The USPTO announced that the Patent Office will be closed on Tuesday in view of President Bush's proclamation that there be a National Day of Mourning for President Gerald R. Ford on January 2, 2007. Because the Patent Office will consider Tuesday to be a "Federal holiday" under 35…
Patent Docs 